Tick (check) box to add article to PDF "basket"
Human papillomavirus has long been associated with the vast majority of cervical and anogenital cancers diagnosed worldwide, but its role in head-and-neck cancers has been less widely researched. In a landmark case study, EU-funded researchers are characterising the connection in order to advance the development of new screening and diagnostic techniques.
Published: 2 September 2015
EU-funded researchers have developed an innovative new cancer treatment. Interest from the pharmaceutical industry has been so great that the research team has set up a company dedicated to bringing their innovations to market.
Published: 1 September 2015
Freely accessible online tools to enable sustainable and efficient water resource management are being developed by the EU-funded SWITCH-ON project. The initiative is currently building a web portal to host innovations such as a virtual water-science laboratory, product marketing point and meeting place.
Published: 25 August 2015
EU-funded researchers are developing a highly accurate, cost-effective and simple-to-use test for malaria. The innovative diagnostic tool, which is being refined and tested in Africa and Asia, promises to save lives through early detection while advancing efforts to eradicate the deadly mosquito-borne disease.
Published: 19 August 2015
Researchers are blazing a trail towards personalised medicine in cancer care. This will mean the provision of new immunotherapy treatments targeting some of the most complicated conditions. In line with this approach an EU-funded project is developing new technologies to help doctors provide targeted, individual treatments. It has so far conducted clinical trials involving eight melanoma patients to demonstrate the potential of this approach.
Published: 18 August 2015
Lung cancer is the leading killer of all cancers worldwide. The outcome depends heavily on when the disease is diagnosed. But therapeutic strategies are also key, and those currently available are only making modest inroads into mortality rates. The EU-funded project WINTHER set out to improve methods for predicting the efficacy of drugs in cancer patients in a ground-breaking new approach to targeted therapies.
Published: 17 August 2015
An EU-funded project is attempting to validate a prototype test designed to predict which combination therapy would best suit individual patients with colorectal cancer, the most common form of cancer in Europe. The test is expected to lengthen the life expectancy for those with this aggressive form of cancer by indicating the most effective treatment combination for individual patients.
Published: 13 August 2015
Prof. Michael Schneider is a leading authority in the field of cardiac molecular biology. In 2008, he obtained an ERC grant to identify the mechanisms governing self-renewal of cardiac progenitor cells, a population of stem cells located in the heart itself that might be exploited to play a key role in regenerating this vulnerable organ in heart disease.
Published: 10 August 2015
Eggs are so much more than yolks and whites. For pharmaceuticals and cosmetics companies, the membrane within the shell is highly prized. With an innovative new technology to separate the membrane from the mineral shell without damaging the former, EU-funded researchers are filling a gap in the market and addressing the waste problem facing companies using eggs.
Published: 6 August 2015
Why should gluten intolerance condemn people to a lifetime of limited - and often bland - food choices? By using new innovative ingredients and techniques to replicate the taste and texture of gluten, an EU-funded project has taken impressive steps to ensure that nothing is off the menu. The project's techniques are also helping Europe's smaller food manufacturers develop new products for the gluten-free market, helping them compete.
Published: 4 August 2015